Skip to content
10-Q

Quarterly Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-21-028406

← back to feed
Filed
Nov 15, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 15, 2021 168.15M sh
Cash And Equivalents Q3 2021 · Sep 30, 2021 $130.5K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $742
Current Liabilities Q3 2021 · Sep 30, 2021 $4.23M
Current Liabilities Q3 2021 · Dec 31, 2020 $3.78M
Total Liabilities Q3 2021 · Sep 30, 2021 $4.87M
Total Liabilities Q3 2021 · Dec 31, 2020 $4.41M
Current Assets Q3 2021 · Sep 30, 2021 $787.97K
Current Assets Q3 2021 · Dec 31, 2020 $722.46K
Total Assets Q3 2021 · Sep 30, 2021 $4.52M
Total Assets Q3 2021 · Dec 31, 2020 $4.71M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$905.51K
Stockholders Equity Q3 2021 · Sep 30, 2020 $252.14K
Stockholders Equity Q3 2021 · Jun 30, 2020 $789.57K
Stockholders Equity Q3 2021 · Mar 31, 2020 $1.08M
Stockholders Equity Q3 2021 · Dec 31, 2019 $1.59M
Net Income Q3 2021 · Sep 30, 2020 −$571.93K
Net Income Q3 2021 · Sep 30, 2020 −$1.91M
Net Income Q3 2021 · Jun 30, 2020 −$317.74K
Net Income Q3 2021 · Mar 31, 2020 −$1.02M
Operating Income Q3 2021 · Sep 30, 2020 −$438.84K
Operating Income Q3 2021 · Sep 30, 2020 −$1.11M
Gross Profit Q3 2021 · Sep 30, 2020 −$8.26K
Gross Profit Q3 2021 · Sep 30, 2020 $362.02K
Revenue Q3 2021 · Sep 30, 2020 $153.77K
Revenue Q3 2021 · Sep 30, 2020 $956.35K